We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
KRON

Price
0.78
Stock movement up
+0.02 (3.00%)
Company name
Kronos Bio Inc
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Biotechnology
Market cap
46.89M
Ent value
10.82M
Price/Sales
4.75
Price/Book
0.42
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-
1 year return
-35.24%
3 year return
-53.07%
5 year return
-
10 year return
-
Last updated: 2025-04-10

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

DIVIDENDS

KRON does not pay dividends or no data was received

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales4.75
Price to Book0.42
EV to Sales1.10

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

FINANCIALS

Per share

Loading...
Per share data
Current share count60.34M
EPS (TTM)-1.42
FCF per share (TTM)-1.29

Income statement

Loading...
Income statement data
Revenue (TTM)9.86M
Gross profit (TTM)7.69M
Operating income (TTM)-80.29M
Net income (TTM)-85.59M
EPS (TTM)-1.42
EPS (1y forward)-

Margins

Loading...
Margins data
Gross margin (TTM)78.00%
Operating margin (TTM)-813.98%
Profit margin (TTM)-867.66%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash74.96M
Net receivables0.00
Total current assets127.92M
Goodwill0.00
Intangible assets0.00
Property, plant and equipment28.07M
Total assets150.02M
Accounts payable1.28M
Short/Current long term debt25.80M
Total current liabilities15.38M
Total liabilities38.90M
Shareholder's equity111.13M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-77.62M
Capital expenditures (TTM)45.00K
Free cash flow (TTM)-77.67M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-77.02%
Return on Assets-57.05%
Return on Invested Capital-74.82%
Cash Return on Invested Capital-67.90%

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open0.74
Daily high0.78
Daily low0.74
Daily Volume133K
All-time high38.23
1y analyst estimate2.25
Beta1.86
EPS (TTM)-1.42
Dividend per share-
Ex-div date-
Next earnings date7 May 2025

Downside potential

Loading...
Downside potential data
KRONS&P500
Current price drop from All-time high-97.97%-10.49%
Highest price drop-98.10%-56.47%
Date of highest drop6 Jun 20249 Mar 2009
Avg drop from high-77.62%-11.07%
Avg time to new high103 days12 days
Max time to new high1098 days1805 days

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

COMPANY DETAILS
KRON (Kronos Bio Inc) company logo
Marketcap
46.89M
Marketcap category
Small-cap
Description
Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of therapeutics for various cancer and other serious diseases in the United States. Its lead product candidates are KB-0742, an oral cyclin dependent kinase 9 inhibitor for the treatment of MYC-amplified solid tumors, which is in phase 2 clinical trial; and KB-9558, a core oncogenic transcription factor that drives multiple myeloma. The company was incorporated in 2017 and is headquartered in San Mateo, California.
Employees
58
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

UNDERSTAND THE BUSINESS
Loading...